New York State Common Retirement Fund’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-62
| Closed | -$1K | – | 3482 |
|
|
2022
Q2 | $1K | Sell |
62
-3,360
| -98% | -$54.2K | ﹤0.01% | 3430 |
|
|
2022
Q1 | $41K | Buy |
3,422
+14
| +0.4% | +$168 | ﹤0.01% | 3206 |
|
|
2021
Q4 | $111K | Sell |
3,408
-20
| -0.6% | -$651 | ﹤0.01% | 3047 |
|
|
2021
Q3 | $153K | Buy |
3,428
+27
| +0.8% | +$1.21K | ﹤0.01% | 3005 |
|
|
2021
Q2 | $185K | Buy |
3,401
+41
| +1% | +$2.23K | ﹤0.01% | 3074 |
|
|
2021
Q1 | $251K | Buy |
3,360
+450
| +15% | +$33.6K | ﹤0.01% | 2743 |
|
|
2020
Q4 | $316K | Sell |
2,910
-1,130
| -28% | -$123K | ﹤0.01% | 2570 |
|
|
2020
Q3 | $357K | Hold |
4,040
| – | – | ﹤0.01% | 2376 |
|
|
2020
Q2 | $431K | Buy |
4,040
+910
| +29% | +$97.1K | ﹤0.01% | 2295 |
|
|
2020
Q1 | $186K | Buy |
3,130
+20
| +0.6% | +$1.19K | ﹤0.01% | 2498 |
|
|
2019
Q4 | $215K | Sell |
3,110
-420
| -12% | -$29K | ﹤0.01% | 2712 |
|
|
2019
Q3 | $366K | Hold |
3,530
| – | – | ﹤0.01% | 2486 |
|
|
2019
Q2 | $327K | Buy |
3,530
+820
| +30% | +$76K | ﹤0.01% | 2580 |
|
|
2019
Q1 | $248K | Hold |
2,710
| – | – | ﹤0.01% | 2624 |
|
|
2018
Q4 | $151K | Hold |
2,710
| – | – | ﹤0.01% | 2827 |
|
|
2018
Q3 | $323K | Hold |
2,710
| – | – | ﹤0.01% | 2613 |
|
|
2018
Q2 | $277K | Buy |
2,710
+1,370
| +102% | +$140K | ﹤0.01% | 2729 |
|
|
2018
Q1 | $174K | Hold |
1,340
| – | – | ﹤0.01% | 2791 |
|
|
2017
Q4 | $130K | Hold |
1,340
| – | – | ﹤0.01% | 2920 |
|
|
2017
Q3 | $197K | Hold |
1,340
| – | – | ﹤0.01% | 2778 |
|
|
2017
Q2 | $216K | Buy |
1,340
+840
| +168% | +$135K | ﹤0.01% | 2809 |
|
|
2017
Q1 | $80K | Hold |
500
| – | – | ﹤0.01% | 3004 |
|
|
2016
Q4 | $61K | Buy |
+500
| New | +$61K | ﹤0.01% | 3037 |
|